Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
B.A.D. Etf stock logo
BAD
B.A.D. Etf
$11.91
$11.91
$11.11
$13.72
$9.77M0.961,591 shsN/A
Amplify Treatments, Testing and Advancements ETF stock logo
GERM
Amplify Treatments, Testing and Advancements ETF
$19.16
$19.16
$15.67
$20.20
$9.58M0.841,891 shsN/A
SPAC and New Issue ETF stock logo
SPCX
SPAC and New Issue ETF
$25.64
+1.1%
$25.14
$22.40
$26.61
$9.74M0.051,485 shs3,878 shs
SSPX
Janus Henderson US Sustainable Equity ETF
$30.10
-0.7%
$28.83
$23.59
$30.89
$9.78M1.16683 shs779 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
B.A.D. Etf stock logo
BAD
B.A.D. Etf
0.00%0.00%0.00%0.00%0.00%
Amplify Treatments, Testing and Advancements ETF stock logo
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%+3.68%
SPAC and New Issue ETF stock logo
SPCX
SPAC and New Issue ETF
+0.85%+0.94%+0.43%+7.10%+9.57%
SSPX
Janus Henderson US Sustainable Equity ETF
-0.66%+0.20%+2.77%+24.59%+9.50%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/AN/AN/AN/AN/AN/AN/AN/A
Amplify Treatments, Testing and Advancements ETF stock logo
GERM
Amplify Treatments, Testing and Advancements ETF
N/AN/AN/AN/AN/AN/AN/AN/A
SPAC and New Issue ETF stock logo
SPCX
SPAC and New Issue ETF
N/AN/AN/AN/AN/AN/AN/AN/A
SSPX
Janus Henderson US Sustainable Equity ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
B.A.D. Etf stock logo
BAD
B.A.D. Etf
0.00
N/AN/AN/A
Amplify Treatments, Testing and Advancements ETF stock logo
GERM
Amplify Treatments, Testing and Advancements ETF
0.00
N/AN/AN/A
SPAC and New Issue ETF stock logo
SPCX
SPAC and New Issue ETF
2.50
Moderate Buy$25.64N/A
SSPX
Janus Henderson US Sustainable Equity ETF
2.75
Moderate Buy$30.10N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/AN/AN/AN/AN/AN/A
Amplify Treatments, Testing and Advancements ETF stock logo
GERM
Amplify Treatments, Testing and Advancements ETF
N/AN/AN/AN/AN/AN/A
SPAC and New Issue ETF stock logo
SPCX
SPAC and New Issue ETF
N/AN/AN/AN/AN/AN/A
SSPX
Janus Henderson US Sustainable Equity ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/AN/A16.67N/AN/AN/AN/AN/A
Amplify Treatments, Testing and Advancements ETF stock logo
GERM
Amplify Treatments, Testing and Advancements ETF
N/AN/A7.10N/AN/AN/AN/AN/A
SPAC and New Issue ETF stock logo
SPCX
SPAC and New Issue ETF
N/AN/A142.96N/AN/AN/AN/AN/A
SSPX
Janus Henderson US Sustainable Equity ETF
N/AN/A28.95N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
B.A.D. Etf stock logo
BAD
B.A.D. Etf
$0.080.67%N/AN/AN/A
Amplify Treatments, Testing and Advancements ETF stock logo
GERM
Amplify Treatments, Testing and Advancements ETF
$0.231.20%N/AN/AN/A
SPAC and New Issue ETF stock logo
SPCX
SPAC and New Issue ETF
$0.160.62%N/AN/AN/A
SSPX
Janus Henderson US Sustainable Equity ETF
$0.100.33%N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
B.A.D. Etf stock logo
BAD
B.A.D. Etf
N/A820,000N/ANot Optionable
Amplify Treatments, Testing and Advancements ETF stock logo
GERM
Amplify Treatments, Testing and Advancements ETF
N/A500,000N/ANot Optionable
SPAC and New Issue ETF stock logo
SPCX
SPAC and New Issue ETF
N/A380,000N/AOptionable
SSPX
Janus Henderson US Sustainable Equity ETF
N/A325,000N/ANot Optionable

Recent News About These Companies

(SSPX) Investment Analysis
Janus Henderson celebrates the $20bn mark for its AAA CLO ETF
How the (SSPX) price action is used to our Advantage
How to Take Advantage of moves in (SSPX)
Learn to Evaluate (SSPX) using the Charts
Janus Henderson Global Sust Eq D
Janus Henderson debuts its first active ETF in Europe
JMID Janus Henderson Mid Cap Growth Alpha ETF
Janus Henderson Global Allocation Gr D
Janus Henderson US (Holdings) Bond
Janus Henderson Global Real Estate Fund Q2 2024 Commentary
Trading (SSPX) With Integrated Risk Controls
Janus Henderson Global Equity Income D

Media Sentiment Over Time

Top Headlines

View All Headlines
B.A.D. Etf stock logo

B.A.D. Etf NYSEARCA:BAD

$11.91 0.00 (0.00%)
As of 11/29/2023

The B.A.D. ETF (BAD) is an exchange-traded fund that is based on the EQM BAD index. The fund tracks a modified equal-weighted index of US-listed companies engaged in betting, alcohol, cannabis, and drugs. BAD was launched on Dec 22, 2021 and is managed by The BAD Investment Company.

Amplify Treatments, Testing and Advancements ETF stock logo

Amplify Treatments, Testing and Advancements ETF NYSEARCA:GERM

$19.16 0.00 (0.00%)
As of 07/3/2025

The ETFMG Treatments, Testing and Advancements ETF (GERM) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases. GERM was launched on Jun 17, 2020 and is managed by ETF Managers Group.

SPAC and New Issue ETF stock logo

SPAC and New Issue ETF NASDAQ:SPCX

$25.64 +0.29 (+1.14%)
As of 07/7/2025 03:55 PM Eastern

The AXS SPAC and New Issue ETF (SPCX) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively-managed fund that aims to provide a broad exposure to Special Purpose Acquisitions Corporations (SPACs) and newly-listed firms. SPCX was launched on Dec 16, 2020 and is managed by AXS Investments.

Janus Henderson US Sustainable Equity ETF NYSEARCA:SSPX

$30.10 -0.20 (-0.66%)
As of 07/7/2025 04:10 PM Eastern

The Janus Henderson U.S. Sustainable Equity ETF (SSPX) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio that seeks long-term capital growth by targeting US companies considered to be contributing positively to the environment and society. SSPX was launched on Sep 8, 2021 and is managed by Janus Henderson.